David Bangsberg, MD, MPH is an Associate Professor Harvard Medical School, and Visiting Professor at Mbarara University of Science and Technology, and Director of the Massachusetts General Hospital Center for Global Health. The MGH Center for Global Health supports 43 programs in 30 countries in order to improve health in the world's most vulnerable populations through leveraging MGH's 200 year history of innovation in medical care and education.

Dr. Bangsberg completed medical school at Johns Hopkins Hospital in Baltimore, his internal medicine residency at Columbia Presbyterian Hospital in New York, and fellowships in Infectious Disease and AIDS Prevention at the University of California, San Francisco. Dr. Bangsberg's research focuses on HIV in impoverished populations. In 1996, Dr. Bangsberg launched a series of studies in HIV+ homeless and marginally housed individuals in response to concerns that poor adherence to HIV antiretroviral treatment in the urban poor would create new strains of drug resistant virus. These studies mitigated what we now recognize were exaggerated concerns regarding HIV drug resistance in the urban poor and helped shift the debate from withholding treatment to maximizing treatment effectiveness. In 2001, Dr. Bangsberg launched a series of studies to address similar concerns that the scale-up of antiretroviral therapy to poor regions of the world would similarly lead to unacceptable levels of drug resistance due to the challenges of adhering to antiretroviral therapy in settings of extreme poverty. Contrary to popular opinion, Dr. Bangsberg found that HIV+ people living in sub-Saharan Africa are better able to adhere to antiretroviral therapy than their counterparts in North America. This work was deemed by the editors of The Lancet as among the most important medical findings for 2006 and was described by President Bill Clinton as the "nail in the coffin "on the debate as to whether the poor in Africa could successfully take their HIV treatment. Dr. Bangsberg founded and continues to lead the HIV research program at the Mbarara University of Science and Technology in Mbarara, Uganda. This program focuses on structural barriers to treatment access and treatment adherence, including poverty reduction to improve transportation to healthcare settings as well as the competing demands of securing food for HIV+ individuals and their families. The program has also developing new technologies to bring the new and established treatment and prevention to the right person at the right time to improve maternal-child health in rural Africa.

Dr. Bangsberg has received research awards from charitable foundations, the National Institutes of Health and the Centers for Disease Control. He was the second highest ranked National Institute of Health RO-1funded investigator in HIV/AIDS in 2007. He is on the Editorial and Advisory Boards of PEPFAR, PLOS Medicine, JAIDS, AIDS Patient Care and STDs, AIDS Care and AIDS and Behavior. He has authored or co-authored over 200 publications in peer-reviewed journals, and several book chapters